Point72 Hong Kong Ltd Has $704,000 Holdings in Doximity, Inc. (NASDAQ:DOCS)

Point72 Hong Kong Ltd grew its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 319.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,187 shares of the company's stock after buying an additional 10,043 shares during the period. Point72 Hong Kong Ltd's holdings in Doximity were worth $704,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in DOCS. Global Retirement Partners LLC raised its holdings in shares of Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after purchasing an additional 440 shares in the last quarter. UMB Bank n.a. grew its holdings in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after buying an additional 235 shares during the last quarter. Larson Financial Group LLC grew its holdings in shares of Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after buying an additional 250 shares during the last quarter. Optimum Investment Advisors purchased a new stake in Doximity in the fourth quarter valued at $43,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in Doximity in the fourth quarter valued at $50,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Robert W. Baird reduced their price target on shares of Doximity from $87.00 to $65.00 and set an "outperform" rating for the company in a research report on Tuesday. The Goldman Sachs Group dropped their price target on shares of Doximity from $80.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday. Leerink Partners raised shares of Doximity from a "market perform" rating to an "outperform" rating and increased their price target for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Raymond James lowered their price objective on shares of Doximity from $83.00 to $65.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Finally, Mizuho reduced their target price on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a report on Friday, May 16th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $61.22.

Doximity Stock Up 1.1%

Doximity stock traded up $0.55 during mid-day trading on Thursday, hitting $51.30. 751,919 shares of the company's stock traded hands, compared to its average volume of 2,088,475. Doximity, Inc. has a one year low of $25.00 and a one year high of $85.21. The firm has a 50 day moving average price of $56.78 and a 200 day moving average price of $57.94. The company has a market cap of $9.58 billion, a PE ratio of 51.32, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same period in the previous year, the business posted $0.25 EPS. The firm's revenue was up 17.1% on a year-over-year basis. On average, analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Buying and Selling at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the completion of the transaction, the director now owns 16,618 shares of the company's stock, valued at $946,062.74. This represents a 10.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Anna Bryson sold 45,000 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the transaction, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at approximately $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 37.40% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.